GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Price-to-Tangible-Book

Calidi Biotherapeutics (Calidi Biotherapeutics) Price-to-Tangible-Book : (As of Jun. 06, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Price-to-Tangible-Book?

As of today (2024-06-06), Calidi Biotherapeutics's share price is $0.194. Calidi Biotherapeutics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-0.41. Hence, Calidi Biotherapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Calidi Biotherapeutics's Price-to-Tangible-Book or its related term are showing as below:

CLDI's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.825
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Calidi Biotherapeutics's share price is $0.194. Calidi Biotherapeutics's Book Value per Sharefor the quarter that ended in Mar. 2024 was $-0.41. Hence, Calidi Biotherapeutics's P/B Ratio of today is .


Calidi Biotherapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Calidi Biotherapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Price-to-Tangible-Book Chart

Calidi Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - - -

Calidi Biotherapeutics Quarterly Data
Dec20 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Calidi Biotherapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Calidi Biotherapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Calidi Biotherapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Calidi Biotherapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Calidi Biotherapeutics's Price-to-Tangible-Book falls into.



Calidi Biotherapeutics Price-to-Tangible-Book Calculation

Calidi Biotherapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=0.194/-0.408
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Calidi Biotherapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Traded in Other Exchanges
N/A
Address
11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines